The DNA testing company 23andMe has gotten FDA approval to screen for 3 BRCA gene mutations linked to a higher risk of breast cancer. But the test raises some concerns. Katie Nielsen of CBS San Francisco station KPIX reports.

Advertisement
Up to 50% Off Men''s Shorts at Eastern Mountain Sports. Hurry, While Supplies Last!

More videos

Ningxia 60 Years
Xinhua 19 Sep 2018 13:32 CEST

Ningxia 60 Years

Pyongyang int'l trade fair
Xinhua 19 Sep 2018 13:30 CEST

Pyongyang int'l trade fair